Liquid Biopsy Market
cancer , leukemia , prostate cancer and other . The end user segment is segregated as hospitals , cancer institutes , diagnostic centers , and academic institutes .
Global Liquid Biopsy Market : Regional Analysis
Geographically , the global liquid biopsy market spread across North America , Asia-Pacific , Europe , Latin America , and the Middle East and Africa . North America is expected to have major growth in the global liquid biopsy market owing to a high number of clinical development projects , accessibility , availability and high presence of advanced technologies in diagnostics such as PCR and NGS . In addition , growing prevalence of cancer in this region may foster the global market growth . In Europe , the global liquid biopsy market is also anticipated to witness favorable growth in coming years due to rising cases of lung cancer . In Asia-Pacific , the global market will witness ample growth in future due to the large presence of population , old ages patients , and implementation of advanced healthcare practices .
Global Liquid Biopsy Market : Competitive Players
Major players in the global liquid biopsy market are Myriad Genetics , Roche , Guardant Health , Inc ., Janssen Diagnostics , LLC , and MDxHealth SA . Other players influencing the global market are BIOCEPT , Inc ., QIAGEN , Trovagene Inc ., Fraunhofer-Gesellschaft , and Natera , Inc .